We attended ASCO 2019. ASCO is the American Society of Clinical Oncology. ASCO hosts, next to many other activities around oncology, an annual meeting.
This meeting provides clinical updates and educational sessions for oncologists, nurses, researchers and everybody interested in oncology from around the world. The 2019 meeting hosted more than 40’000 participants, an increase of ca. 30% over the last 7 years. The growth of participants indicates the level of innovation and investments which flow into the sector. These aspects stayed the same compared to previous years. However, a lot of other things have changed in 2019.
After weeks of containment efforts, some governments dip their toe into the uncertain waters of re-opening parts of the economy. What needs to be in place in order to get back to a certain state of normalcy? And how does testing help in this endeavour?
As the world grapples with the outbreak of SARS-CoV-2 and people across the world experience dramatic cuts to their freedom of movement, the healthcare sector is racing to find solutions to tackle the current pandemic. How quickly could treatments for COVID-19 realistically become available?
We attended the 9th Annual SVB Leerink Global Healthcare Conference in New York from February 25 to 27, 2020, which hosted over 200 healthcare companies. As the spread of COVID-19 hit the markets this week, it was also the number one topic at the conference.